id:"swepub:oai:DiVA.org:uu-498006"
Search: id:"swepub:oai:DiVA.org:uu-498006" > NT-proBNP and stem ...
- 1 of 1
- Previous record
- Next record
- To hitlist
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
- Rossignol, P (author)
- Duarte, K (author)
- Bresso, E (author)
- show more...
- A, Åsberg (author)
- Devignes, M D (author)
- Eriksson, N (author)
- Girerd, N (author)
- Glerup, R (author)
- Jardine, A G (author)
- Holdaas, H (author)
- Lamiral, Z (author)
- Leroy, C (author)
- Massy, Z (author)
- März, W (author)
- Krämer, B (author)
- Schmieder, R (author)
- Christensen, J H (author)
- Svensson, M (author)
- Zannad, F (author)
- show less...
- (creator_code:org_t)
- 2022-11-09
- 2022
- English.
- In: European Heart Journal Open. - : Oxford University Press. - 2752-4191. ; 2:6
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Aimas: End-stage renal disease (ESRD) treated by chronic hemodialysis (HD) is associated with poor cardiovascular (CV) outcomes, with no available evidence-based therapeutics. A multiplexed proteomic approach may identify new pathophysiological pathways associated with CV outcomes, potentially actionable for precision medicine.Methods and Results: The AURORA trial was an international, multicentre, randomized, double-blind trial involving 2776 patients undergoing maintenance HD. Rosuvastatin vs. placebo had no significant effect on the composite primary endpoint of death from CV causes, nonfatal myocardial infarction or nonfatal stroke. We first compared CV risk-matched cases and controls (n = 410) to identify novel biomarkers using a multiplex proximity extension immunoassay (276 proteomic biomarkers assessed with OlinkTM). We replicated our findings in 200 unmatched cases and 200 controls. External validation was conducted from a multicentre real-life Danish cohort [Aarhus-Aalborg (AA), n = 331 patients] in which 92 OlinkTM biomarkers were assessed. In AURORA, only N-terminal pro-brain natriuretic peptide (NT-proBNP, positive association) and stem cell factor (SCF) (negative association) were found consistently associated with the trial's primary outcome across exploration and replication phases, independently from the baseline characteristics. Stem cell factor displayed a lower added predictive ability compared with NT-ProBNP. In the AA cohort, in multivariable analyses, BNP was found significantly associated with major CV events, while higher SCF was associated with less frequent CV deaths.Conclusions: Our findings suggest that NT-proBNP and SCF may help identify ESRD patients with respectively high and low CV risk, beyond classical clinical predictors and also point at novel pathways for prevention and treatment.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Keyword
- Cardiovascular
- Chronic hemodialysis
- NT-proBNP
- Prognosis
- Stem cell factor
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- European Heart Journal Open (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Rossignol, P
- Duarte, K
- Bresso, E
- A, Åsberg
- Devignes, M D
- Eriksson, N
- show more...
- Girerd, N
- Glerup, R
- Jardine, A G
- Holdaas, H
- Lamiral, Z
- Leroy, C
- Massy, Z
- März, W
- Krämer, B
- Wu, Ping-Hsun, 1 ...
- Schmieder, R
- Soveri, Inga
- Christensen, J H
- Svensson, M
- Zannad, F
- Fellström, Bengt ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Urology and Neph ...
- Articles in the publication
- European Heart J ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
